tiprankstipranks
Trending News
More News >
Alibaba Health Information Technology (HK:0241)
:0241
Advertisement

Alibaba Health Information Technology (0241) Stock Statistics & Valuation Metrics

Compare
19 Followers

Total Valuation

Alibaba Health Information Technology has a market cap or net worth of HK$80.43B. The enterprise value is HK$67.24B.
Market CapHK$80.43B
Enterprise ValueHK$67.24B

Share Statistics

Alibaba Health Information Technology has 16,123,642,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding16,123,642,000
Owned by Insiders
Owned by Institutions

Financial Efficiency

Alibaba Health Information Technology’s return on equity (ROE) is 0.09 and return on invested capital (ROIC) is 8.80%.
Return on Equity (ROE)0.09
Return on Assets (ROA)0.07
Return on Invested Capital (ROIC)8.80%
Return on Capital Employed (ROCE)0.10
Revenue Per Employee21.52M
Profits Per Employee1.10M
Employee Count1,422
Asset Turnover1.44
Inventory Turnover16.37

Valuation Ratios

The current PE Ratio of Alibaba Health Information Technology is 52.2. Alibaba Health Information Technology’s PEG ratio is 1.17.
PE Ratio52.2
PS Ratio2.31
PB Ratio4.34
Price to Fair Value4.34
Price to FCF51.47
Price to Operating Cash Flow52.94
PEG Ratio1.17

Income Statement

In the last 12 months, Alibaba Health Information Technology had revenue of 30.60B and earned 1.43B in profits. Earnings per share was 0.09.
Revenue30.60B
Gross Profit7.43B
Operating Income1.58B
Pretax Income1.56B
Net Income1.43B
EBITDA1.62B
Earnings Per Share (EPS)0.09

Cash Flow

In the last 12 months, operating cash flow was 1.40B and capital expenditures 0.00, giving a free cash flow of 1.40B billion.
Operating Cash Flow1.40B
Free Cash Flow1.40B
Free Cash Flow per Share0.09

Dividends & Yields

Alibaba Health Information Technology pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share
Dividend Yield
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta2.18
52-Week Price Change53.07%
50-Day Moving Average4.61
200-Day Moving Average4.39
Relative Strength Index (RSI)63.13
Average Volume (3m)147.70M

Important Dates

Alibaba Health Information Technology upcoming earnings date is Dec 2, 2025, TBA (Not Confirmed).
Last Earnings DateMay 19, 2025
Next Earnings DateDec 2, 2025
Ex-Dividend Date

Financial Position

Alibaba Health Information Technology as a current ratio of 2.59, with Debt / Equity ratio of 0.22%
Current Ratio2.59
Quick Ratio2.29
Debt to Market Cap0.00
Net Debt to EBITDA-1.35
Interest Coverage Ratio604.09

Taxes

In the past 12 months, Alibaba Health Information Technology has paid 127.95M in taxes.
Income Tax127.95M
Effective Tax Rate0.08

Enterprise Valuation

Alibaba Health Information Technology EV to EBITDA ratio is 42.37, with an EV/FCF ratio of 49.89.
EV to Sales2.24
EV to EBITDA42.37
EV to Free Cash Flow49.89
EV to Operating Cash Flow49.21

Balance Sheet

Alibaba Health Information Technology has HK$8.10B in cash and marketable securities with HK$35.52M in debt, giving a net cash position of -HK$8.06B billion.
Cash & Marketable SecuritiesHK$8.10B
Total DebtHK$35.52M
Net Cash-HK$8.06B
Net Cash Per Share-HK$0.50
Tangible Book Value Per ShareHK$0.94

Margins

Gross margin is 24.29%, with operating margin of 5.15%, and net profit margin of 4.68%.
Gross Margin24.29%
Operating Margin5.15%
Pretax Margin5.10%
Net Profit Margin4.68%
EBITDA Margin5.30%
EBIT Margin5.11%

Analyst Forecast

The average price target for Alibaba Health Information Technology is HK$5.81, which is 11.43% higher than the current price. The consensus rating is Hold
Price TargetHK$5.81
Price Target Upside16.40% Upside
Analyst ConsensusHold
Analyst Count5
Revenue Growth Forecast-1.97%
EPS Growth Forecast25.45%

Scores

Smart Score6
AI Score74
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis